Results 161 to 170 of about 839,337 (241)

Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study [PDF]

, 2023
Chiara Suffritti, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Cristina Novembrino, Anna Lecchi, Silvia La Marca, Lidia Padovan, Erica Scalambrino, Marigrazia Clerici, Patrizia Bono, Ferruccio Ceriotti, Antonio Muscatello, Simona Maria Siboni, Flora Peyvandi   +14 more
openalex   +1 more source

mRNA-1273 cinical development program [PDF]

COVID-02-Miller-508 ...

core  

mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates [PDF]

, 2022
Adam T. Waickman, Kaitlin Victor, Krista L. Newell, Tao Li, Heather Friberg, Kathryn E. Foulds, Mario Roederer, Diane L. Bolton, Jeffrey R. Currier, Robert A. Seder   +9 more
openalex   +1 more source

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial [PDF]

, 2023
Dean Follmann, Holly Janes, Eric Chun‐Pu Chu, Lakshmi Jayashankar, Christos J. Petropoulos, Leonid Serebryannyy, Robin Carroll, Naz Jean-Baptiste, Sandeep Narpala, Bob C. Lin, Adrian B. McDermott, Richard M. Novak, Daniel S. Graciaa, Stephanie Rolsma, Craig A. Magaret, Nicole A. Doria‐Rose, Lawrence Corey, Kathleen M. Neuzil, Rolando Pajón, Jacqueline M. Miller, Rubén O. Donis, Richard A. Koup, Lindsey R. Baden, Hana M. El Sahly   +23 more
openalex   +1 more source

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

Human Vaccines & Immunotherapeutics
The objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV).
A. Naficy, A. Kuxhausen, Harry Seifert, Andrew Hastie, B. Leav, Jacqueline Miller, Kate Anteyi, A. Mwakingwe-Omari   +7 more
semanticscholar   +1 more source

Referee report. For: Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain [version 2; peer review: 1 approved]

, 2022
Manushak Avagyan
openalex   +1 more source

Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals [PDF]

, 2021
Duaa W. Al‐Sadeq, Farah M. Shurrab, Ahmed Ismail, Fathima Humaira Amanullah, Swapna Thomas, Nader Al‐Dewik, Hadi M. Yassine, Hanan F. Abdul Rahim, Laith J. Abu‐Raddad, Gheyath K. Nasrallah   +9 more
openalex   +1 more source

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients

New England Journal of Medicine, 2021
Victoria G Hall, V. Ferreira, T. Ku, M. Ierullo, B. Majchrzak-Kita, C. Chaparro, N. Selzner, J. Schiff, Michael A McDonald, G. Tomlinson, V. Kulasingam, Deepali Kumar, A. Humar   +12 more
semanticscholar   +1 more source

Estimating the Public Health and Economic Impact of Annual mRNA COVID-19 Vaccination for Adults Aged 50 and Older in South Korea’s Endemic Era

Vaccines
Background/Objectives: COVID-19 continues to challenge public health due to emerging variants. To mitigate this, the Korea Disease Control and Prevention Agency (KDCA) recommends annual COVID-19 vaccination, but uptake remains suboptimal.
Jaehee Jung, Dain Lee, Hee-Do Yang, Ah-Young Kim, Haeun Lee, Minkyoung Kang, Ekkehard Beck, Keya Joshi, Youngju Kang, Hye-Young Kang   +9 more
doaj   +1 more source

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors [PDF]

, 2021
Madison Ballman, Shannon Swift, Cristina Mullenix, Yvonne Mallory, Chen Zhao, Éva Szabó, Meenakshi Shelat, Susan Sansone, Seth M. Steinberg, Meredith J. McAdams, Arun Rajan   +10 more
openalex   +1 more source